These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
687 related articles for article (PubMed ID: 8522958)
1. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. Dahmer MK; Senogles SE J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958 [TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors. Dahmer MK; Senogles SE J Neurochem; 1996 Nov; 67(5):1960-4. PubMed ID: 8863501 [TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach. Coronas V; Krantic S; Jourdan F; Moyse E Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hormonally induced inositol trisphosphate production in Transfected GH4 sup>C1 cells: A novel role for the D5 subtype of the dopamine receptor. White BH; Kimura K; Sidhu A Neuroendocrinology; 1999 Mar; 69(3):209-16. PubMed ID: 10087453 [TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum. Olianas MC; Onali P J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium. Bacic F; Uematsu S; McCarron RM; Spatz M J Neurochem; 1991 Nov; 57(5):1774-80. PubMed ID: 1681036 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory mechanism of bromocriptine on catecholamine release evoked by cholinergic stimulation and membrane depolarization from the rat adrenal medulla. Lim DY; Lee YG; Kim IH Arch Pharm Res; 2002 Aug; 25(4):511-21. PubMed ID: 12214865 [TBL] [Abstract][Full Text] [Related]
8. Cross-talk between M2 muscarinic and D1 dopamine receptors in the cat adrenal medulla. Albillos A; Abad F; García AG Biochem Biophys Res Commun; 1992 Mar; 183(3):1019-24. PubMed ID: 1348929 [TBL] [Abstract][Full Text] [Related]
9. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Meschler JP; Howlett AC Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162 [TBL] [Abstract][Full Text] [Related]
10. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release? Starr M J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468 [TBL] [Abstract][Full Text] [Related]
11. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction. Lee D; Huang W; Lim AT Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767 [TBL] [Abstract][Full Text] [Related]
12. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex. Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E receptors in bovine adrenal medulla are coupled to adenylate cyclase via Gi and to phosphoinositide metabolism in a pertussis toxin-insensitive manner. Negishi M; Ito S; Hayaishi O J Biol Chem; 1989 Mar; 264(7):3916-23. PubMed ID: 2537296 [TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway. Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052 [TBL] [Abstract][Full Text] [Related]
15. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function. Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914 [TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway. Santanavanich C; Ebadi M; Govitrapong P J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro. Rossi NF Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089 [TBL] [Abstract][Full Text] [Related]
18. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors. Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005 [TBL] [Abstract][Full Text] [Related]
19. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182 [TBL] [Abstract][Full Text] [Related]
20. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride. Battaglia G; Norman AB; Hess EJ; Creese I J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]